Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease
J Med Microbiol
.
2010 Feb;59(Pt 2):141-143.
doi: 10.1099/jmm.0.017541-0.
Epub 2009 Nov 26.
Authors
Filip Van Immerseel
1
,
Richard Ducatelle
1
,
Martine De Vos
2
,
Nico Boon
3
,
Tom Van De Wiele
3
,
Kristin Verbeke
4
,
Paul Rutgeerts
4
,
Benedikt Sas
5
,
Petra Louis
6
,
Harry J Flint
6
Affiliations
1
Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
2
Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium.
3
Laboratory of Microbial Ecology and Technology (LabMET), Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
4
Department of Gastroenterology and Leuven Food Science and Nutrition Research Centre (LFoRCe), University Hospital, Leuven, Belgium.
5
Centre of Excellence Food2Know, Ghent University, Ghent, Belgium.
6
Microbial Ecology Group, Gut Health Programme, Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.
PMID:
19942690
DOI:
10.1099/jmm.0.017541-0
No abstract available
Publication types
Editorial
MeSH terms
Bacteria, Anaerobic / metabolism*
Butyric Acid / metabolism*
Fermentation
Humans
Inflammatory Bowel Diseases / therapy*
Probiotics / pharmacology*
Substances
Butyric Acid